Advances in Cell Based Assays

Description

SMi Group invites you to attend the market leading cell based event, Advances in Cell Based Assays, taking place on 11th & 12th November in Central London.

We have worked closely with an array of industry KOLs and scientific leaders to host a packed conference agenda for the 7th annual conference this autumn

Expand your scientific horizons as we ask the questions:

•    How have recent advances in high throughput sample expression techniques opened up new possibilities for primary HTS within the biologics industry?
•    What are the current challenges of bioassay method development and how can we validate these with reference to cell based assays and regulatory guidelines in drug development?
•    What is the next generation of target identification and screening technologies?
•    How easy is it to use adult stem cells in therapeutic applications, in vitro and in vivo paradigm?
•    How can we exploit gene editing in human cell lines to provide novel, isogenic assays?
•    How are new technologies impacting the industry?
•    3D cell culture, how can this be used in oncology research?
•    What is the next generation of cell based assays?

Key Speakers Include:

•    Steve Ludbrook, Group Leader, Biological Sciences UK, RD Platform Technology & Science, GSK
•    Beverley Isherwood, Team Leader High Content Biology, Innovative Medicines, AstraZeneca R&D
•    Dr Lesley Jenkinson, Scientist 1, Medimmune
•    Dr Farnaz Fallah-Arani, Group Leader, Pharmacology, UCB
•    Neil Carragher, PhD, Principal Investigator Drug Discovery, Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh
•    Niclas Nilsson, Head of Section, Lead Discovery, LEO Pharma
•    Dr Christa Burger, Principal Scientist, Cellular Pharmacology, Merck Serono
•    Dr Marianne Uteng, PhD, Head of Cellular Models & HCB Laboratory, Discovery and Investigative Safety (DIS), Novartis
•    Anker Jon Hansen, Principal Scientist, Novo Nordisk
•    Daniel Nolan, Director of Research, Angiocrine Bioscience